Correlation of estrogen sulfotransferase activity and proliferation in normal and carcinomatous human breast. A hypothesis

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3219-3225

  Pasqualini, Jorge Raul ^a   Chetrite, Gerard Samuel ^b  

^a Institut de Puericulture   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Breast cancer; Estrogen sulfotransferase; Proliferation

Indexed keywords

ESTROGEN SULFOTRANSFERASE; MEDROGESTONE; NOMEGESTROL ACETATE; PROGESTERONE DERIVATIVE; PROMEGESTONE; TIBOLONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; CELL GROWTH PROCESSES; HUMANS; NORPREGNENES; PROGESTINS; SULFOTRANSFERASES;

EID: 35348997446     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dao TL, Hayes C and Libby PR: Steroid sulfatase in human breast tumors. Proc Soc Exp Biol Med 146: 381-384, 1974.
2. Tseng L, Mazella J, Lee LY and Stone ML: Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma. J Steroid Biochem 19: 1413-1417, 1983.
3. Wild MJ, Rudland PS and Back DJ: Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR 75-1) human breast cells in culture. J Steroid Biochem 39: 535-543, 1991.
4. Pasqualini JR: Steroid sulphotransferase activity in the human hormone-independent MDA-MB-468 mammary cancer cells. Eur J Cancer 28A: 758-762, 1992.
5. Sharp S, Anderson JM and Coughtrie MWH: Immunohistochemical localisation of hydroxysteroid sulphotransferase in human breast carcinoma tissue: a preliminary study. Eur J Cancer 30A: 1654-1658, 1994.
6. Blanchard RB, Freimuth RR, Buck J, Weinshilboum RM and Coughtrie MWH: A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14: 199-211, 2004.
7. Anderson E and Howell A: Oestrogen sulphotransferases in malignant and normal human breast tissue. Endocr Related Cancer 2: 227-233, 1995.
8. Falany JL and Falany CN: Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56: 1551-1555, 1996.
9. Falany JL and Falany CN: Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone. Endocrinology 137: 1395-1401, 1996.
10. Qian Y-M, Sun XJ, Tong MH, Li XP, Richa J and Song W-C: Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 142: 5342-5350, 2001.
11. Falany JL, Lawing L and Falany CN: Identification and characterization of cytosolic sulfotransferase activities in MCF-7 human breast carcinoma cells. J Steroid Biochem Molec Biol 46: 481-487, 1993.
12. Dooley TP: Cloning of the human phenol sulfotransferase gene family: three genes implication in the metabolism of catecholamines, thyroid hormones and drugs. Chem Biol Interact 109: 29-41, 1998.
13. Dooley TP, Haldeman-Cahill R, Joiner J and Wilborn TW: Expression profiling of human sulfotransferase and sulfatase gene superfamilies in epithelial tissues and cultured cells. Biochem Biophys Res Commun 277: 236-245, 2000.
14. Falany CN, Wheeler J, Oh TS and Falany JL: Steroid sulfation by expressed human cytosolic sulfotransferases. J Steroid Biochem Molec Biol 48: 369-375, 1994.
15. Zajchowski DA, Sager R and Webster L: Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res 53: 5004-5011, 1993.
16. Falany JL and Falany CN: Regulation of estrogen activity by sulfation in MCF-7 human breast cancer cells. Oncol Res 9: 589-596, 1997.
17. Qian Y, Deng C and Song W-C: Expression of estrogen sulfotransferase in MCF-7 cells by cDNA transfection suppresses the estrogen response: potential role of the enzyme in regulating estrogen-dependent growth of breast epithelial cells. J Pharmacol Exp Ther 286: 555-560, 1998.
18. Gompel A, Malet C, Spritzer P, Lalardrie J-P, Kuttenn F and Mauvais-Jarvis P: Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63: 1174-1180, 1986.
19. Gill PG, Tilley WD, De Young NJ, Lensink IL, Dixon PD and Horsfall DJ: Inhibition of T-47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF. Breast Cancer Res Treat 20: 53-62, 1991.
20. Malet C, Spritzer P, Guillaumin D and Kuttenn F: Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture. J Steroid Biochem Molec Biol 73: 171-181, 2000.
21. McManus MJ and Welsch CW: The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 54: 1920-1927, 1984.
22. Longman SM and Buehring GC: Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer 59: 281-287, 1987.
23. Chetrite G, Paris J, Botella J and Pasqualini JR: Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. J Steroid Biochem Molec Biol 58: 525-531, 1996.
24. Chetrite GS, Thomas JL, Shields-Botella J, Cortes-Prieto J, Philippe J-C and Pasqualini JR: Control of sulfatase by nomegestrol acetate in normal and cancerous human breast tissues. Anticancer Res 25: 2827-2830, 2005.
25. Botella J, Duranti E, Duc I, Cognet AM, Delansorne R and Paris J: Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T-47D human breast cancer cells. J Steroid Biochem Molec Biol 50: 41-47, 1994.
26. Shields-Botella J, Due I, Duranti E, Puccio F, Bonnet P, Delansorne R and Paris J: An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells. J Steroid Biochem Molec Biol 87: 111-122, 2003.
27. Kloosterboer HJ: Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Molec Biol 76: 231-238, 2001.
28. Kloosterboer HJ, Schoonen WG, Deckers GH and Klijn JG: Effects of progestagens and Org-OD14 in in vitro and in vivo tumor models. J Steroid Biochem Molec Biol 49: 311-318, 1994.
29. Gompel A, Chaouat M, Jacob D, Perrot JY, Kloosterboer HJ and Rostene W: In vitro studies of tibolone in breast cells. Fertil Steril 78: 351-359, 2002.
30. Chetrite G, Le Nestour E and Pasqualini JR: Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines. Effect of the progestin, promegestone (R-5020). J Steroid Biochem Molec Biol 66: 295-302, 1998.
31. Chetrite GS, Ebert C, Wright F, Philippe J-C and Pasqualini JR: Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines. J Steroid Biochem Molec Biol 70: 39-45, 1999.
32. Chetrite GS, Paris J, Shields-Botella J, Philippe J-C and Pasqualini JR: Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines. Anticancer Res 23: 4651-4656, 2003.
33. Chetrite GS, Kloosterboer HJ, Philippe J-C and Pasqualini JR: Effect of Org-OD14 (Livial®) and its metabolites on human oestrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Anticancer Res 19: 269-276, 1999